Skip to main content

Advertisement

SpringerLink
Log in

“Ecstasy”-induced neurotoxicity: the contribution of functional brain imaging

  • Editorial Commentary
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, et al. Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. Neuropsychopharmacology 1999;20:565–81

    Article  PubMed  Google Scholar 

  2. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4–methylenedioxymethamphetamine (“ecstasy”). Lancet 1992;340:384–7

    Article  PubMed  Google Scholar 

  3. Ricaurte GA, Martello AL, Katz JL, Martello MB. Lasting effects of (+−)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther 1992;261:616–22

    PubMed  Google Scholar 

  4. Ricaurte GA, Yuan J, McCann UD. (+/−)3,4-Methylene-dioxymethamphetamine (‘Ecstasy’)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 2000;42:5–10

    Article  PubMed  Google Scholar 

  5. McCann UD, Eligulashvili V, Ricaurte GA. (+/−)3,4-Methylene-dioxymethamphetamine (‘Ecstasy’)-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology 2000;42:11–6

    Article  Google Scholar 

  6. Battaglia G, Yeh SY, De Souza EB. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 1988;29:269–74

    Article  PubMed  Google Scholar 

  7. Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte G. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/−)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). J Neurosci 1995;15:5476–85

    PubMed  Google Scholar 

  8. Hatzidimitriou G, McCann UD, Ricaurte GA. Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/−)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 1999;19:5096–107

    PubMed  Google Scholar 

  9. Gouzoulis-Mayfrank E, Daumann J, Sass H. Neurotoxische Langzeitschäden bei Ecstasy (MDMA)-Konsumenten. Nervenarzt 2002;73:405–21

    Article  PubMed  Google Scholar 

  10. Schreckenberger M, Gouzoulis-Mayfrank E, Sabri O, Arning C, Zimmy M, Zeggel T, et al. “Ecstasy”-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology. An 18-FDG PET study. Eur J Nucl Med 1999;26:1572–9

    Article  PubMed  Google Scholar 

  11. Obrocki J, Buchert R, Vaterlein O, Thomasius R, Beyer W, Schiemann T. Ecstasy—long-term effects on the human central nervous system revealed by positron emission tomography. Br J Psychiatry 1999;175:186–8

    PubMed  Google Scholar 

  12. Buchert R, Obrocki J, Thomasius R, Vaterlein O, Petersen K, Jenicke L et al. Long-term effects of ‘ecstasy’ abuse on the human brain studied by FDG PET. Nucl Med Commun 2001;22:889–97

    Article  PubMed  Google Scholar 

  13. Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, et al. Long-term effects of “ecstasy” use on serotonin transporters of the brain investigated by PET. J Nucl Med 2003;44:375–84

    PubMed  Google Scholar 

  14. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA. Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings. Lancet 1998;352:1433–7

    Article  PubMed  Google Scholar 

  15. Reneman L, Habraken JB, Majoie CB, Booij J, den Heeten GJ. MDMA (“Ecstasy”) and its association with cerebrovascular accidents: preliminary findings. Am J Neuroradiol 2000;21:1001–7

    PubMed  Google Scholar 

  16. Semple DM, Ebmeier KP, Glabus MF, O’Carroll RE, Johnstone EC. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users. Br J Psychiatry 1999;175:63–9

    PubMed  Google Scholar 

  17. Siessmeier T, Zhou Y, Buchholz HG, Landvogt C, Vernaleken I, Piel M, et al. Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. J Nucl Med 2005;46:964–72

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Johannes Gutenberg-University Mainz, Langenbeckstrasse 1, 55101, Mainz, Germany

    M. Schreckenberger

Authors
  1. M. Schreckenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Schreckenberger.

Additional information

This editorial commentary refers to the article http://dx.doi.org/10.1007/s00259-005-1850-8

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schreckenberger, M. “Ecstasy”-induced neurotoxicity: the contribution of functional brain imaging. Eur J Nucl Med Mol Imaging 33, 185–187 (2006). https://doi.org/10.1007/s00259-005-1968-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-005-1968-8

Keywords

Search

Navigation